Political Science Faculty Publications and Presentations
Document Type
Article
Publication Date
2013
Abstract
Congress has consistently failed to solve some serious problems with the cost, effectiveness, and safety of pharmaceuticals. In part, this failure results from the pharmaceutical industry convincing legislators to define policy problems in ways that protect industry profits. By targeting campaign contributions to influential legislators and by providing them with selective information, the industry manages to displace the public’s voice in developing pharmaceutical policy.
Recommended Citation
Jorgensen P. D. (2013). Pharmaceuticals, political money, and public policy: a theoretical and empirical agenda. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 41(3), 561–570. https://doi.org/10.1111/jlme.12065
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Publication Title
Journal of Law, Medicine & Ethics
DOI
10.1111/jlme.12065
Comments
Original published version available at https://doi.org/10.1111/jlme.12065